Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice by unknown
Intrinsic B  Cell Defects in NZB and NZW Mice Contribute 
to Systemic Lupus Erythematosus in (NZB  ￿  NZW)F1  Mice 
By Luc Reininger,* Thomas H.Winkler,r  Christian  P. Kalberer,~ 
Michel Jourdan,* Fritz Melchers,* and Anton  G. 1Lolink$ 
From *Institut National de la Santd et de la Recherche MMicale U291, F-34197 Montpellier, 
France; and *Basel Institute  for Immunology,  CH-4005 Basel, Switzerland 
Summary 
We have previously shown that long-term in vitro proliferating fetal liver pre-B cell lines de- 
rived from autoimmune-prone (NZB  ￿  NZW)F1  (BW) mice, but not normal (B6 ￿  DBA/ 
2)F1  mice, can differentiate in severe combined immunodeficient (SCID) mice to produce el- 
evated levels of serum immunoglobulin (Ig) M and IgG, and high titers ofantinuclear antibodies. 
The contribution of parental NZB  and NZW strains  to B  cell abnormalities  of BW hybrid 
mice was  investigated here by preparing pre-B cells and transferring them into immunodefi- 
cient SCID- and RAG-2-targeted mice. We show that transfer of NZB pre-B cells led to a 
marked lgM hypergammaglobulinemia and to the production of limited amounts  of IgG2a. 
On the other hand, the transfer ofNZW pre-B cell lines led to moderately elevated IgM levels 
and marked hypergammaglobulinemia of IgG2a. High IgM and low IgG anti-DNA titers are 
found in the recipients of NZB pre-B cells,  whereas those receiving NZW pre-B cells con- 
tained lower levels of IgM and high titers of IgG anti-DNA.  In marked contrast, essentially 
identical titers of antibodies directed against  a non-self-antigen, DNP, are found in all groups 
ofpre-B cell recipients. Thus, B-lineage cells of both NZB and NZW parental strains manifest 
abnormalities associated with the development of this lupus-like disease. Therefore, the present 
study strongly suggests  a  complex inheritance of B  cell abnormalities  in  autoimmune-prone 
(NZB ￿  NZW)FI mice and emphasizes the critical importance of intrinsic B cell defects in the 
development of routine systemic lupus erythematosus. 
M 
ice of the hybrid (NZB  ￿  NZW)F1  (BW) sponta- 
.neously develop an autoimmune disease  closely re- 
sembling SLE (1).  The disease  is characterized by the ap- 
pearance  of elevated serum levels of IgG antibodies  with 
reactivities to nuclear antigens  such as histones and DNA 
and by IgG antiretroviral envelope glycoprotein gp70 anti- 
bodies that have been implicated in the development of a 
fatal immune complex-mediated glomerulonephritis (2-6). 
Mice of the parental NZB strain show a modified form of 
autoimmune  disease  with  hemolytic anemia  as  the  lethal 
outcome, due to the production of anti-mouse RBC  au- 
toantibodies  (7).  In  contrast,  NZW  mice  are  phenotypi- 
cally normal until late in life,  although it has  been shown 
that they have the potential to develop an early severe SLE 
disease either by chronic injection ofpolyclonal B cell acti- 
vators (8) or by mating with nonautoimmune mice bearing 
the Y chromosome from BXSB mice (9). Earlier and more 
recent  segregation  analyses  in  reciprocal  backcrosses  be- 
tween NZB and NZW mice as well as studies of recombi- 
nant inbred lines have revealed a  complex inheritance of 
the  SLE disease  in BW mice  (10-17).  Multiple genes are 
contributed  either from the  parental  NZB  or NZW  ge- 
nome.  Their gene products  can enhance  or suppress  the 
disease, and they may be expressed in different cell lineages. 
Since the polyclonal B  cell activation is the earliest and 
most common immunological abnormality of NZB, BW, 
and other strains  of mice with spontaneous SLE disease,  an 
excessive B  cell activity has  long been thought to be the 
primary  immunological  abnormality  leading  to  autoim- 
mune disease  (18,  19). Most notably, NZB mice exhibit a 
marked increase of IgM secretion beginning even early in 
life, and precursor B cell development is enhanced and ac- 
celerated (20,  21). An enhanced in vitro responsiveness of 
B cells from BW mice to accessory cell-derived signals has 
also been demonstrated, suggesting that intrinsic abnormal- 
ities  affect BW D-lineage cells  (22).  The similarities  of B 
cell  abnormalities  in  NZB  and  BW  hybrid mice  suggest 
that genetic defects responsible for spontaneous polyclonal 
B  cell activation in BW mice could be inherited from the 
NZB parental strain.  By contrast, NZW mice do not ex- 
hibit signs of spontaneous polyclonal B  cell activation, and 
their B cells are not as obviously abnormal as those of NZB 
mice (18). Since NZW parental genes, which contribute in 
a major way to the disease  development in BW mice, are 
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repertoire may be one major NZW  factor contributing to 
disease (12,  14,  16,  17).  In fact, in addition to the possible 
abnormality of B  cells, it has been  clearly established that 
CD4 + T  cells play a crucial role in the pathogenesis of SLE 
in BW mice (23). Thus, the contribution of the NZW  pa- 
rental strain to B  cell abnormalities of BW mice is less clear. 
The  possibility of establishing  B  lymphocyte  lineage- 
committed progenitors and precursors in culture and trans- 
ferring  them  into  SCID  hosts  enabled  us  to  study  BW- 
encoded disease-inducing genes that are expressed in the B 
lymphocyte lineage (24, 25). We observed that SCID mice 
populated with pre-B cells of BW mice, but not those pop- 
ulated with (B6  ￿  DBA/2)F1 pre-B cells, developed many 
of the characteristics of autoimmune-prone mice. Most no- 
tably, injection ofBW  pre-B cells led to hypergammaglob- 
ulinemia of IgM, IgG2a, and IgG3 and elevated serum lev- 
els of IgM and  IgG antinuclear antibodies (ANA) ~ for the 
next 3  to  5  too.  Furthermore,  a  subset of recipient SCID 
mice developed proteinuria associated with IgG deposits in 
their kidneys. These  results  provided  direct evidence  that 
genetic  defects  responsible for  the  development  of lupus 
disease in BW  mice are expressed in their B-lineage cells. 
To  further  investigate the genetics of BW  intrinsic B  cell 
defects, we used the following experimental system. Pre-B 
cell lines, derived from the parental NZB and NZW  strains 
and from  (NZW  ￿  B6)FI  hybrid, were  transferred to re- 
cipient SCID- and KAG-2-deficient mice. Results of this 
analysis are discussed as evidence for the polygenic control 
of B  cell abnormalities in lupus-prone BW mice and for the 
dual contribution of NZB and NZW  parental strains. 
Materials  and Methods 
Mice.  NZB and NZW mice were purchased from Bomhol- 
gard Ltd. (Ry, Denmark). C57BL/6  (B6) and DBA/2 mice came 
from IFFA CREDO  (L'Arbresle, France). Pregnant female mice 
were  obtained by local breeding.  CB17-SCID  mice  were  ob- 
tained from IFFA CREDO  and were routinely tested for serum 
lg before use.  RAG-2T mice were originally obtained from F. 
Alt (Children's Hospital, Boston, MA) and bred in our own ani- 
mal facilities. Blood samples were collected by orbital sinus ponc- 
tion, and the sera were stored at -20~  until use. 
Cell Lines and Tissue Culture Conditions.  The stromal cell line 
PA-6  was  obtained from  Dr.  H.A.  Kodama  (Ohu  University, 
Ohu, Japan). PA-6- and IL-7-dependent pre-B cells were grown 
in  Iscove's  modified  Dulbecco's  medium  (IMDM)  containing 
100  U/ml kanamycin,  5  X  10 -5 M  2-mercaptoethanol, 0.03% 
primaton, and 2%  heat-inactivated fetal calf serum.  Culture su- 
pernatants  of nmrine  recombinant  1L-7  cDNA-J558  myeloma 
cell transfectants  grown in IMDM containing 5% fetal calf serum 
were added to pre-B cell cultures at 2% final concentration as the 
source of IL-7 (representing "-~100-200  U/ml). 
Preparation and Transfer of Pre-B Cells.  Isolation of mouse fetal 
liver pre-B cell lines was previously described in detail (24). Fetal 
liver cells at days 17 and 18 of gestation were directly cloned in 
96-well flat-bottomed microculture plates at a  concentration of 
I  Abbreviation used in this paper: ANA, Antinuclear antibodies. 
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50 nucleated cells/ml on a serniconfluent layer of 3,000  rad x-irra- 
diated PA-6 stromal cells in the presence of IL-7. In vitro differ- 
entiation to sIg  § cells was performed in culture with stromal cells, 
but without IL-7, for 3-4 d. 2-3 too-old CB17 SCID or KAG-2T 
mice were irradiated with 300 or 400 rad, respectively, and, 4-6 h 
after irradiation, injected intravenously with 5 X  10  (' ceils of three 
pooled pre-B cell lines. 
Monoclonal Antibodies and Cytofluorometric Analysis.  The  follow- 
ing mAbs were used: G5-2 (anti-PB76);  14.8  (anti-B220); Ack4 
(anti-c-kit); $7  (anti-CD43); M41  (anti-mouse Ix); GK1.5  (anti- 
mouse CD4); and 53.6.7  (anti-mouse CD8). For details, see ref- 
erences in Rolink et al.  (24).  For immunofluorescence analysis, 
mAbs were purified on protein G-Sepharose and coupled to biotin 
as described previously (24).  F1TC- and PE-labeled streptavidin 
were purchased from Amersham (Amersham, UK) and Imnmno- 
tech (Marseille, France), respectively. The biotin-conjugated R5- 
240  (anti-mouse K)  and 1K26-46 (anti-mouse k)  were  obtained 
from Pharmingen (San Diego, CA). Double immunofluorescent 
analysis was performed with the help of FlTC-labeled Y3  mAb 
(anti-H-2 K b)  (26).  Staining of the cells was done as previously 
described (27). Fluorescent intensity was measured with a FACScan  | 
(Becton Dickinson & Co., Mountain View, CA). 
Quantification of Ig Levels and Determination of Anti-DNP Anti- 
body Titers.  Total levels of sermn lgM and IgG subclasses were 
determined by ELISA as previously described (25),  using unla- 
beled and alkaline phosphatase-labeled goat antibodies specific for 
mouse  Ig classes and subclasses  (purchased from Southern  Bio- 
technology Associates Inc., Birmingham, AL). The lg concentra- 
tions were determined by referring to standard curves obtained 
with known concentrations of mouse Ig (Southern Biotechnol- 
ogy Associates Inc., and ICN Biomedicals, Inc, Costa Mesa, CA). 
Serum levels of IgM and  lgG anti-DNP  antibodies were  mea- 
sured by ELISA in which DNPv)-BSA was used as coating anti- 
gen.  DNPlv-BSA  was  a  gift  from  Dr.  S.  Izui  (University  of 
Geneva,  Geneva,  Switzerland). Results  are  expressed as  a  per- 
centage of a serum pool of B6 mice injected with LPS for IgM 
class antibodies, and as a percentage of a serum pool of 4-too-old 
MRL-lpr/lpr mice for IgG class antibodies. 
Detection of Autoantibodies.  The  presence  of anti-DNA  anti- 
bodies was  assessed by  an  ELISA as  previously described  (28). 
Wells were coated with single-stranded calf thymus DNA (Type 
V; Sigma Chemical Co., St. Louis, MO) at a concentration of 10 
txg/ml. The serum levels ofanti-DNA antibodies are expressed as 
relative concentrations in reference to  standard curves obtained 
with serial dilutions of a serum pool collected from B6  mice at 
day 8  after injection of LPS for IgM antibodies and of a serum 
pool of 3-4-mo-old lupus-prone MKL-lpr/Ipr mice for IgG anti- 
bodies. 
ANA were detected by indirect immunofluorescence on Hep-2 
cells  using  FITC-labeled goat  anti-mouse  Is-specific reagents 
(Southern Biotechnology Associates  Inc.) as previously described 
(28). The initial serum dilution was 1:20. 
In vivo bound anti-mouse RBC antibodies were detected by di- 
rect anti-MRBC ILIA as described previously (29). 
Statistical Analysis.  Statistical analysis was performed with the 
Mann-Whitney test. Probability values >5% were considered in- 
significant. 
Results 
Population  of SCID-  and RAG-2-deficient  Mice  with  Fetal 
Liver Pre-B Cell Lines Derived from Normal BDF1, Autoimmune- 
prone B W, or Parental NZB and NZW  Mice.  We showed pre- 
Genetic Defects Expressed in B-lineage Cells of New Zealand Mice Table 1.  Levels  of Serum Ig and Anti-DNA Antibodies in 3- to 5-mo-old Control and Pre-B Cell-populated Mice 
Ig concentrations*  Anti-DNA* 
Group  n*  IgM  IgG3  IGg2a  IgG  1  IgG2b  IgM  IgG 
~g/ml  % 
BDF1  5  280 •  50  205  •  75  1150  •  200  670 •  120  1060  •  190  1.5 •  0.5  <0.1 
--+SCID  8  145  •  50  155  •  45  110  •  75  <20  75  •  55  1.5 •  1.2  <0.1 
BW  6  1050  •  140  735  •  295  2880 •  655  1100  •  250  1095  •  145  16.6  •  5.2  8.5 •  4.6 
--+SCID  7  735  •  130  650 •  190  1020  •  560  95 •  110  140 •  100  12.6  •  7.1  4.7 •  5.0 
--+RAG  8  1275  •  490  465  •  225  590 •  285  <20  110  •  30  11.8  •  4.8  3.1  •  2.5 
NZB  8  1290  •  200  670 ~  220  1680  •  590  1010  •  335  850 •  260  23.6  •  6.5  1.6 •  2.1 
--+SClD  12  790  •  315  305  •  300  125  •  100  135  •  140  140  •  130  24.1  •  17.8  0.1  •  0.1 
--+RAG  8  1575  •  460  670  •  385  275  •  140  <20  115  •  70  29.3  •  13.1  0.2 •  0.1 
NZW  8  205  •  15  100 •  10  1590  •  215  1260  •  285  655  •  90  1.9 •  0.4  0.4 •  0.2 
--+SCID  9  370 •  135  410 •  150  1805  •  1200  230 •  270  150  •  65  7.3 •  1.3  13.5  •  14.0 
--+RAG  9  435  •  315  540  •  340  1270  •  865  25 •  75  74 •  40  4.7 •  1.8  5.6 •  5.5 
(NZW￿  B6)F1  5  295  •  105  190 •  15  960 •  205  2255  •  535  765  •  155  1.8 •  0.2  0.3 •  0.3 
--+RAG  8  900 •  275  485  •  370  <20  <20  130 •  65  9.8 •  6.5  0./  •  0.2 
"Number of mice tested per group. 
*Results are the mean of 5 to 12 mice +  SD. Ig concentrations are expressed in I.tg/ml; IgM and IgG anti-DNA antibodies are expressed as relative 
concentration  by reference to standard curves obtained with a pool serum of C57BL/6  mice at day 8 after intraperitoneal injection ofS0 ixg Salmo- 
nella Minnesota R595 lipopolysaccharides and with a pool serum of 3-4-mo-old MRL-lpr/lpr mice, respectively. 
viously that  fetal liver-derived pre-B  cell lines from  BW 
mice can differentiate in SCID mice and produce elevated 
levels of serum IgM and IgG as well as high titers of ANAs. 
To  rule  out  the  possibility that  small numbers  of SCID- 
derived T  cells are responsible for the spontaneous IgG and 
IgG autoantibody production, we also used RAG-2-deficient 
hosts  here.  As  previously  observed,  SCID  mice  injected 
with pre-B  cell lines from non-autoimmune-prone  BDF1 
mice developed normal levels of serum IgM, very little se- 
rum IgG, and no anti-DNA autoantibodies of the IgG class 
(Table  1).  In contrast,  the transfer of BW pre-B  cell lines 
led to the spontaneous production of increased levels of se- 
rum  IgM,  IgG2a,  and  IgG3 both  in SCID  and  RAG-2T 
hosts  (P  <0.001).  It  should  be  noted  that  we  observed 
slight differences in the IgM and IgG2a levels in the SCID 
and RAG-2T  mice populated with BW pre-B cells. These 
differences may reflect variations of the host environment. 
Both SCID and RAG-2T  mice populated with BW pre-B 
cells developed  elevated  and  similar serum  levels of IgM 
and  IgG  anti-DNA  antibodies  (Table  1),  indicating  that 
both phenomena  were indeed T  cell independent and oc- 
curred as result of intrinsic B  cell defects. 
The contribution of parental NZB  and NZW  strains to 
B  cell abnormalities of BW hybrid mice was further inves- 
tigated by using the same  experimental system.  Pre-B  cell 
lines proliferating for several weeks on stromal cells in the 
presence of IL-7 were  established from fetal liver of NZB 
and NZW  mouse  embryos at days 17 and  18  of gestation. 
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Their properties were comparable to those described previ- 
ously (24).  All cell lines expressed the  pre-B  cell markers 
PB76,  c-kit, CD43,  and B220,  indicating that they corre- 
spond to pre-B  I  cells (30).  They did not express ~H  and 
KL chain on the surface, and they were capable of differen- 
tiating in vitro to  slg  + B  cells within 3  to  4  d  when  IL-7 
was removed from the cultures (data not shown).  Pools of 
two  to  three  NZB  or NZW  pre-B  cell lines were  trans- 
ferred  into  immunodeficient  SCID  and  P,  AG-2T  mice. 
We then determined Ig serum levels each month after their 
injection during a 5-mo period of observation. The results 
obtained at month 3 posttransfer are shown in Fig. 1. Table 1 
summarizes the results of SCID and RAG-2T  mice repop- 
ulated  with  pre-B  cells  and  compares  these  findings  to 
those made in normal control mice. 
Following the injection of NZB  pre-B  cells, a  majority 
of SCID  and  RAG-2T  mice  developed  levels  of serum 
IgM  that were  markedly elevated at month  3  posttransfer 
compared to those of mice injected with BDF1 pre-B cells 
(P <0.001).  In contrast, in SCID and R.AG-2T mice pop- 
ulated with  NZW  pre-B  cells, levels of serum  IgM were 
slightly, yet significantly, increased (P <0.05).  The  serum 
levels of IgM remained constant for the next 2 mo.  Similar 
to the recipients of BW or BDF1  pre-B cells, recipients of 
NZB  pre-B  cells developed levels of serum  IgM  that  did 
not  differ markedly from  those  observed in  age-matched 
3-4-mo-old control NZB  mice  (Table  1).  In contrast, se- 
rum  IgM  levels  in  recipients  of NZW  pre-B  cells  were ,--,  2000- 
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Serum levels of IgM and IgG subclasses in individual SCID 
(A) and R.AG-2T (B) mice repopulated with 5 ￿  tff' NZB, NZW, or 
(NZW ￿  B6)F1 pre-B cells at 3 m￿9 posttransfer, lg concentrations are 
expressed in Ixg/ml. (Lines)  median values for each group of mice. 
slightly  increased  by  comparison  to  age-matched  NZW 
mice,  which  have  concentrations  similar to  immunologi- 
cally normal mice. 
The analysis of IgG subclasses  showed that except for se- 
rum  IgG3  (P  <0.001),  the  serum  concentrations  of any 
IgG  subclasses  remained  at  low  levels  in  hosts  receiving 
NZB pre-B cells. Mice injected with NZW pre-B cells de- 
veloped increased levels of serum IgG3 both in SCID and 
RAG-2T mice  (P <0.01)  but in  addition  produced  high 
levels of serum IgG2a (P <0.001).  In the  majority of the 
sera, levels of IgG1 and IgG2b remained at low levels. The 
IgG levels remained  constant  during  the  5-too  period  of 
observation.  Surprisingly,  no  enhanced  IgG2a production 
was apparent in 3-4-mo-old NZW  control mice as com- 
pared to normal BDF1  mice (Table 1). 
Development of lgM,  but Not IgG, Hypergammaglobulinemia 
in Recipients of (NZW X  B6)FI Pre-B Cells.  The observa- 
tion that the transfer of NZW,  BW,  but not NZB pre-B 
cells leads to the production of high levels of serum IgG2a 
raised the possibility that dominant genes from the NZW 
genome were responsible for the elevated IgG2a antibody 
production  in  recipients  of pre-B  cells  of BW  origin.  To 
test this, proliferating fetal liver pre-B cell lines were estab- 
lished from (NZW X B6)F1 mouse embryos, according to 
the procedure  described  in  reference 24,  and  were  trans- 
ferred into RAG-2T recipients. Transfer of (NZW X B6)FI 
pre-B cells led to high levels of serum IgM (P <0.001) that 
were even higher than those in recipients of NZW pre-B 
cells  (Fig.  1). Serum IgG3 was increased in the majority of 
mice (P <0.01);  whereas serum lgG2a was undetectable in 
these mice. It should be noted that (NZW  ￿  B6)F1  con- 
trol  mice  have  normal  levels  of serum  IgM,  lgG3,  and 
IgG2a,  although  their  levels  of IgG1  were  increased  by 
comparison to normal BDF1 mice (P <0.001)  (Table 1). 
Spontaneous Production of Anti-DNA  Antibodies  of D!fferent 
Ig Is￿9  in Hosts of NZB or NZW  Pre-B Cells.  To  assess 
the role of NZB and NZW B cell defects in the spontane- 
ous autoimmune responses, serum levels of anti-DNA anti- 
bodies were determined in the SCID and RAG-2T recipi- 
ents  of pre-B  cells.  R.esults  of this  analysis  at  month  3 
posttranst~r (Table  1) showed that by comparison to those 
of BDF1  pre-B cells,  mice injected with NZB pre-B cells 
developed  markedly  elevated  serum  levels  of IgM  anti- 
DNA antibodies (P <0.001) and no detectable serum levels 
of IgG anti-DNA  antibodies.  In contrast,  in  recipients  of 
NZW  pre-B cells,  the levels of IgM anti-DNA antibodies 
were moderately, yet significantly increased (three- to five- 
fold; P  <0.01),  but their levels of IgG anti-DNA antibod- 
ies were markedly elevated (P <0.001).  Notably, titers  of 
IgM and IgG anti-DNA antibodies in mice populated with 
BW  pre-B  cells  were  intermediate  between  those  popu- 
lated with NZB or NZW pre-B cells. After the transfer of 
pre-B  cells  derived  from  (NZW  X  B6)F1  hybrid  mice, 
there  was  spontaneous  production  of high  titers  of IgM 
anti-DNA  antibodies  but undetectable  levels of IgG anti- 
DNA antibodies.  Sinfilar to  the  increased levels of serum 
IgM, the levels of IgM anti-DNA antibodies were twofold 
higher than after transfer of NZW pre-B cells. 
The IgG subclass  distribution of anti-DNA antibodies in 
the sera of mice injected with pre-B cells was further ana- 
lyzed. Fig. 2 shows that the enhanced IgG anti-DNA anti- 
body production in mice populated with NZW pre-B cells 
appeared selective for the lgG2a subclass both in SCID and 
R.AG-2T recipients;  16 out of 18 NZW-populated SCID 
and  RAG-2T  mice  developed  significant  titers  of IgG2a 
anti-DNA  antibodies,  whereas  10  and  7  mice  produced 
anti-DNA antibodies oflgG3 and IgG2b subclasses,  respec- 
tively. Only two individual NZW-populated mice had ele- 
vated levels of IgG1 anti-DNA antibodies, which  strongly 
argues against the participation of host T  cells in the forma- 
tion  of IgG anti-DNA  antibodies  in  the  group  of SCID 
mice.  It  should  be  noted  that  the  predominance  of the 
IgG2a subclass among anti-DNA antibodies in NZW-pop- 
856  Genetic Defects Expressed in B-lineage Ceils of New Zealand Mice r 
O 
,< 
Z 
~0 
2,0 
1,5 - 
1,0 - 
0,5 - 
0,0 - 
2,0 
1,5 - 
1,0 - 
0,5 - 
0,0 - 
2,0 
1,5 - 
1,0 - 
0,5 - 
0,0- 
2,0 
1,5 - 
1,0 - 
0,5 - 
0,0- 
A 
B 
C 
D 
I 
AAA 
￿9  @  o 
oo 
o 
I  I  J 
o 
o  i 
o@ 
o 
￿9  o  o 
o  o 
i  " 
￿9  o 
I  I  I  I 
BDF1  BW  BDF1  BW  NZB  NZW 
pre-B  ~>SCID/RAG-2T 
Figure  2.  Subclass  distribution  of IgG anti-DNA antibodies  in the sera 
of 6-8-mo-old BDF1 (A) and BW (&) female mice and in the sera of 
SCID (O) and RAG-2T (0) mice 3 mo after injection of 5 ￿  lff' BDF1, 
BW,  NZB,  or  NZW-derived pre-B cells. (A)  IgGl; (B)  IgG2a; (C) 
IgG2b; (D) IgG3. All sera were tested at dilution 1:1000. ODs were red 
within the same time after substrate addition. For comparison, OD values 
obtained with a pool serum of 3-4-too-old MRL-Ipr/Ipr  mice tested at 
dilution 1:8000 were for IgG1,0.44; IgG2a, 0.90; IgG2b, 0.32; and lgG3, 
0.98. 
ulated mice is similar to  that seen in BW-populated mice 
and normal B.W control mice. 
The analysis of ANA in the sera of SCID mice 3 mo af- 
ter injection ofNZB pre-B cells similarly revealed a higher 
incidence of mice producing ANA of IgM class (6:10) than 
of IgG isotype (2:10), whereas in contrast, the recipients of 
NZW pre-B cells demonstrated a higher incidence of ANA 
of IgG isotype (8:9) than oflgM ANA formation (0:9). 
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Figure 3.  Titers  ofanti-DNP (O) and anti-DNA (D) antibodies  in the 
serum of individual SCID mice 3 mo after injection of 5 ￿  1if'  BDF1, 
NZB, NZW,  or BW-derived pre-B cells. (A) IgM class; (B) lgG class. 
Twofold serum dilutions  were tested starting  with lgM and IgG concen- 
trations of 1 btg/ml and 20 ~tg/ml as being 1, respectively. The titers are 
the highest dilutions  still giving a positive signal  in the ELISA. 
Since  a  spontaneous production  of antibodies reactive 
with erythrocytes is responsible for the development of an 
autoimmune hemolytic anemia in NZB mice, we have in- 
vestigated the presence of erythrocyte-specific antibodies in 
mice populated with NZB pre-B cells. We found no au- 
toantibodies specific for erythrocytes in the mice populated 
with  either NZB  or  NZW  pre-B  cells,  and none of the 
mice manifested signs of anemia during the period of ob- 
servation (data not shown). 
Selective Production of Anti-DNA Antibodies in Hosts of Pre- 
B  Cells Derived from  ,New Zealand  but  Not  Normal  BDF1 
Mice.  We  further investigated whether the  high  sponta- 
neous production of anti-DNA antibodies reflects the poly- 
clonal activation of B  cells or a selective activation of anti- 
DNA  autoreactive  cells.  With  this  in mind,  the  titers  of 
IgM  and  IgG  anti-DNA  antibodies  were  compared  to 
those  of antibodies against a  foreign antigen, namely, the 
hapten DNP.  The titer of these IgM and IgG antibody re- 
sponses were normalized by using identical amounts of se- 
rum IgM and IgG. Accordingly, if anti-DNA autoreactive 
B  cells of New Zealand origin were  selectively activated, 
we  would  expect  that  the  titers  of anti-DNA antibodies 
would not correlate with concentrations of total serum Ig 
and anti-DNP antibodies and would be increased by com- 
parison to those of mice populated with normal BDF1 pre- B  cells.  Results of this analysis  (Fig.  3)  indicated that titers 
of IgM and IgG anti-DNP  antibodies were comparable in 
all  groups  of pre-B  cell  recipients  when  identical  serum 
concentrations were used in the ELISA assay. Thus, levels 
of IgM and IgG anti-DNP antibodies appeared to correlate 
with  those  of total  serum  IgM  and  IgG, respectively.  In 
contrast, the titers of IgM and IgG anti-DNA antibodies in 
mice reconstituted with NZB or NZW pre-B cells, respec- 
tively, were markedly elevated when compared to those in 
the  group  of mice populated with BDF1  pre-B  cells.  Al- 
though this phenomenon was less apparent in the group of 
mice with BW pre-B cells, their titers of lgM and IgG anti- 
DNA  antibodies  were  also  elevated.  Similar  results  were 
obtained when  1KAG-2T mice were  used  as recipients  of 
pre-B cells (data not shown). 
Discussion 
The contribution of the NZB and NZW parental strains 
to the genetic defects expressed in B lineage ceils of (NZB  X 
NZW)F1 mice, (i.e.,  B cell hyperactiviw, spontaneous IgG 
class-switching,  and  anti-DNA  antibody  production)  was 
analyzed. IL-7 and stromal cell-dependent pre-B cell lines 
prepared from NZB and NZW mice were transferred into 
immunodeficient SCID and P,.AG-2T mice. The develop- 
ment  of  hypergammaglobulinemia  and  the  spontaneous 
production of anti-DNA antibodies in recipients populated 
with either NZB or NZW pre-B cells demonstrate that ge- 
netic  defects affect not  only B-lineage  cells  of the  lupus- 
prone NZB strain but also those of the nondiseased NZW 
mouse strain. This study emphasizes the critical importance 
of intrinsic  B  cell  defects  in  the  development  of murine 
SLE and further suggests that the susceptibility of BW mice 
to SLE might be related to the combined expression of sev- 
eral genetic defects in B lymphocytes acting in concert. 
The finding that the recipients of NZW pre-B cells de- 
veloped high levels of serum IgG2a and IgG anti-DNA an- 
tibodies not present in hosts receiving pre-B cells from im- 
munologically nomlal BDFI mice clearly demonstrates that 
the  NZW  strain  contains  genetic  defects that  can be  ex- 
pressed in  their B-lineage cells.  In previous genetic analy- 
ses,  the  presence  of the  NZW  haplotype  of the  MHC 
(H-2  ~) has been shown to correlate best with autoimmune 
phenomena and disease  development of BW mice (10,  12, 
14). These findings led to the hypothesis that NZW class II 
MHC  genes  might be major contributors  to  the  autoim- 
nmne disease  of BW mice and that CD4 + T  cells  are in- 
volved in the switch of autoantibodies from the lgM to the 
IgG class. The ability of NZW B-lineage cells to produce 
IgG anti-DNA antibodies in the absence ofT cells suggests 
that the mapping of NZW  autoimmune predisposition to 
the H-2 locus may not be related to T  cell recognition or 
antigen presentation by class II molecules. NZW genes that 
have been proposed to contribute  to the  development of 
autoimmunity in BW mice include TNF-o~ (31),  which is 
located within  the the H-2 locus and has a unique  NZW 
allele  (32).  Our present data do not rule out the possibility 
that the IgG anti-dsDNA antibody production in BW mice 
involves  T  cells  such  as  the  nucleosome-specific  T  cell 
clones described by Mohan et al.  (33).  Particularly autoan- 
tibodies of the  IgG1 isotype and somatic mutations of the 
antibodies are likely to occur under T  cell dependence. 
The  present  demonstration  that  B  cells  of the  NZW 
strain manifest defects in  absence of T  cells  is  compatible 
with  the  existence  of  other  lupus  susceptibility  loci  in 
NZW mice, indicating that other non-MHC loci contrib- 
ute  to  the  development of autoimmune  disease  (16,  17). 
This  notion  is  also  evident  from the  studies  of Schiffen- 
bauer et al.  (34),  in which PL/J mice with NZW-identical 
class  I1  molecules  do  not  result  in  autoimnmnity  when 
crossed to NZB. In fact, mice of the NZW strain are gen- 
erally believed to be unaffected, although females develop, 
late  in  life,  a  form  of clinically  silent  glomerulonephritis 
characterized by granular IgG deposits in the kidney capri- 
lary loops resembling those of BW hybrid (35).  The possi- 
bili W of inducing an autommmne disease  in NZW mice by 
polyclonal B  cell stimulators and their susceptibility to the 
Yaa-gene-mediated autoinmmnity  accelerating  effect also 
support the idea that the NZW strain contains primary im- 
munological defects (8, 9). 
A striking finding of this study is that B-lineage cells  of 
NZW  origin manifest abnormalities that are not obviously 
apparent  in  NZW  mice  (18),  since  NZW  control  mice 
have levels of serum IgG2a similar to normal controls and 
do not produce elevated levels of lgG anti-DNA antibod- 
ies.  It is  also  significant  that  the  recipients  of (NZW  ￿ 
B6)F1  pre-B  cells  developed  high  levels  of serum  lgM, 
hence demonstrating B cell hyperactivity,,  whereas (NZW X 
B6)F1  control  mice  failed  to  exhibit  a  similar  increased 
IgM production.  The  discrepancy between  the  recipients 
of pre-B  cells  and  the  corresponding  control  mice  is  at 
present not clear. It is likely that T  cells absent from SCID 
and RAG-2T mice can markedly modulate the spontane- 
ous  activation  of B  lymphocytes.  In  agreement  with  this 
hypothesis, we found that  (NZW  ￿  B6)F1  mice develop 
normal levels of serum IgM and  IgG3; however,  their se- 
rum concentrations  of the T  ceil-dependent  IgG1  isotype 
are significantly enhanced by comparison to normal BDF1 
mice.  It should be noted that the balance of lymphokines 
produced by CD4 + T  cell subsets is known to regulate IgG 
production  (36).  We have also  recently  observed that  the 
constitutive expression of IL-4 in lupus-prone mice is able 
to reduce the spontaneous IgG2a and IgG3 production and 
inhibit  the  development  of lupus  nephritis,  suggesting  a 
role for T helper cell subsets in modulating B cell activation 
and  influencing  the  disease  outcome  (Santiago,  M.-L.,  L. 
Fossati,  C. Jacquet,  W.  Mfiller, S.  lzui,  and L.  1Keininger, 
unpublished results). 
The  development  of IgM hypergammaglobulinemia in 
mice populated with NZB pre-B cells is in good agreement 
with  previous  analyses  indicating  that  B  lymphocytes  of 
NZB mouse strain are polyclonally activated even early in 
life (18,  20), a trait that could be expected to occur at least 
partly as a result of B cell abnormalities. In the NZB strain, 
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secretion  and  IgM anti-DNA  antibody production.  Here 
we show that this feature is shared by mice populated with 
NZB pre-B cells. Since we have not observed the presence 
of autoantibodies against other self-antigens such as eryth- 
rocytes, a type of autoantibody having a major pathogenic 
significance in the development of autoimmune hemolytic 
anemia of NZB mice (7),  one needs to consider the possi- 
bility that B cell defects may not be sufficient to explain the 
formation of all  autoantibodies.  The absence of these  au- 
toantibodies  could be interpreted  to  mean  that  these  au- 
toantibody responses  are  strictly T  cell dependent  or that 
they are controled by genes expressed in other cell lineages. 
The  observation that  anti-DNA  antibodies  appeared to 
be selectively produced compared to anti-DNP antibodies 
in mice populated with NZB or NZW pre-B ceils suggests 
that both strains contain common or similar genetic defects 
in  establishing B  cell  tolerance  to  this  self antigen.  It has 
been  shown  that  within  individual  BW  mice,  both  IgM 
and IgG anti-DNA antibodies may be produced by clonally 
related  B  cells,  strongly  arguing  that  IgM  and  IgG  anti- 
DNA antibodies are the result of an antigen-driven selec- 
tion (37).  A molecular analysis  of a panel of anti-DNA hy- 
bridomas obtained from our experimental system indicates 
that B cells from BW mice differentiate and expand to gen- 
erate clonally related IgM and IgG antibodies even in the 
absence ofT cells (Winkler, T., unpublished results).  How- 
ever,  the  anti-DNA  reactive  B  cells  in  the  SCID  and 
RAG-2T mice may be unable to undergo somatic hyper- 
mutation  and  therefore  may not  acquire  high  affinity for 
double-stranded DNA (37,  38). This could explain the fact 
that recipients ofBW pre-B cells develop only limited signs 
of glomerulonephritis  (25).  Our  data  extend  the  finding 
that B cells expressing a transgenic anti-DNA autoantibody 
are activated in the context of the Ml<L-Ipr genetic back- 
ground, although they undergo deletion or anergy in non- 
autoimmune  mouse  strains  (39,  40),  and  hence,  strongly 
support the hypothesis that defects in B  cell tolerance play 
an important role in systemic autoimmunity. 
The present  demonstration  that B-lineage  cells  of both 
NZB  and  NZW  strains  manifest  abnormalities  associated 
with  the  development  of SLE  in  BW  mice  is  consistent 
with the idea that this lupus-like disease  is under polygenic 
control (16,  17).  The genetic defects responsible for B  cell 
abnormalities of the NZB and NZW strains could contrib- 
ute to the development ofSLE of BW animals as a function 
of the accumulation of independent lupus susceptibility al- 
leles as suggested by a study from Morel et al. (16). Accord- 
ingly, the predominant IgG2a anti-DNA antibody forma- 
tion observed both in mice populated with NZW  or BW 
pre-B cells  is arguing for a role of NZW  dominant genes 
controlling this autoimmune trait in BW mice. This con- 
clusion is consistent with a study by Kohno et al.  (11)  on 
the  progeny  of BW  ￿  NZB  backcross  mice,  suggesting 
that two unlinked dominant NZW genes were responsible 
for the class conversion of anti-DNA antibodies from IgM 
to  IgG1  and  IgG2  subclasses  in  BW  naice.  Kotzin  and 
Palmer (14) found IgG anti-DNA antibodies in 40-50% of 
BW  ￿  NZB backcross mice and  concluded  that a  single 
dominant gene  of the  NZW  is required for elevated IgG 
anti-DNA antibody production in the BW hybrid.  Alter- 
natively, the inheritance of the enhanced isotype switch to 
IgG2a  may  be  dependent  on  a  specific  combination  of 
genes  shared by the  NZB  and  the  NZW  strains  (41).  In 
such a model, the  genetic  contribution to a given trait, in 
this case to IgG anti-DNA antibody production, would be 
dependent  on specific combinations of genes. This would 
explain our finding that B cells from (NZW ￿  B6)F1 mice 
do  not  manifest increased  lgG2a class switching  and  class 
conversion of anti-DNA antibodies. 
In  view  of the  strong  association  of the  spontaneous 
polyclonal activation of B  lymphocytes and disease  devel- 
opment in the various murine lupus  models  (19),  the  ge- 
netic  defects responsible  for B  cell abnormalities  of NZB 
and NZW  are likely to play a major role in the  develop- 
ment  of SLE  in  BW  mice.  This  conclusion  is  consistent 
with the requirement for B cell abnormalities for the devel- 
opment  of hypergammaglobulinemia  and  anti-DNA  au- 
toantibody  production  observed in  mice bearing  the  au- 
toimmune accelerating lpr gene or the uncharacterized Yaa 
mutant gene present on the Y  chromosome of BXSB mice 
(42,  43).  Clearly,  the  present  demonstration  that  genetic 
abnormalities  of NZB  and  NZW  mouse  strains  are  ex- 
pressed at the level of their B  cells  should help to identify 
genetic factors involved in the susceptibility to lupus disease 
and to elucidate the immunopathogenetic mechanism of SLE. 
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